Dear Editor,
Allogeneic or autologous hematopoietic stem cell transplantation (HSCT) allows many patients with hematological malignancies to obtain prolonged survival and often disease cure. Autologous HSCT is particularly effective in acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML) after relapse with conventional treatment. However, iatrogenic endocrine disturbances and reproductive failure are frequently-encountered late effects, which have a major impact on the quality of life.
1 Conditioning regimens with total body irradiation (TBI) and intensive chemotherapy before autologous or allogeneic HSCT are known to cause permanent infertility, a risk that can be prevented by sperm banking. 2 While few cases of successful conception or spermatogenic recovery after HSCT, with chemotherapy alone, or combined with TBI conditioning, have been reported 1, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] (Table 1) , other studies assessing male fertility after HSCT have not reported any conception, highlighting the increased risk of altered reproductive function after HSCT. In 2010, the patient was still in complete remission. Because of the fear of relapse, sperm cryopreservation was planned. Semen parameters were assessed in August 2010 according to WHO classification: the volume was 4.3 ml, the concentration 127310 6 ml 21 with 46% vitality and 30% motility (20% rapid linear progression and 10% slow progression). Sperm morphology using the David criteria showed 29% normal forms. Sperm DNA fragmentation was assessed by the TUNEL assay (In Situ Cell Death Detection Kit, Fluorescein; Roche Applied Science, Meylan, France), which found an increase in the DNA fragmentation rate reaching 30%. Fluorescence in situ hybridization was performed and no sperm aneuploidy was noted for chromosomes 13, 21, X and Y. In January 2012, the couple conceived a second child. The pregnancy is still ongoing.
This case report emphasizes the possibility for men to restart spermatogenesis after HSCT conditioning and to spontaneously conceive healthy children, even after repeated azoospermia diagnosis. Repeated sperm controls are needed, even many years after HSCT. Indeed, the time-to-pregnancy between HSCT and conception has often increased in the case reports ( Table 1) . It is also of importance to inform a couple who do not plan to conceive children that the observed azoospermia may be transient, and the use of contraceptive methods should, when indicated, be envisaged. Very few cases of spermatogenic recovery after HSCT for APL have been published: for the first time, the status of the nucleus was available. Despite moderate sperm DNA fragmentation, no chromosome anomaly was observed and the patient's healthy child does not suffer from any congenital abnormalities. Indeed, both cancer and high doses of radiation and chemotherapeutic agents have been associated with genomic instability, suggesting a possible transmission of DNA damage to the offspring through sperm cells. in cancer survivors have been published; an increased aneuploidy evaluated 6 months after treatment, reverted to pre-treatment values after a few years. 15 Most of the studies conducted on offspring of cancer survivors failed to show any increased incidence of congenital abnormalities. 16 Further investigations and more case reports are needed to assess the effect of HSCT on sperm chromosomes.
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